[{"submitter_treatment_id":null,"program_id":null,"submitter_donor_id":null,"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy","Stem cell transplant","Radiation therapy"],"is_primary_treatment":"Yes","treatment_start_date":"2021-05","treatment_end_date":"2022-04","treatment_setting":"Induction","treatment_intent":"Screening","days_per_cycle":null,"number_of_cycles":5,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Immune partial response (iPR)","line_of_treatment":5,"status_of_treatment":"Unknown"},
{"submitter_treatment_id":null,"program_id":null,"submitter_donor_id":null,"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":"2021-11","treatment_end_date":"2022-10","treatment_setting":null,"treatment_intent":"Curative","days_per_cycle":1,"number_of_cycles":4,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Stable disease","line_of_treatment":5,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_treatment_id":null,"program_id":null,"submitter_donor_id":null,"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Chemotherapy","Surgery"],"is_primary_treatment":"Yes","treatment_start_date":"2021-08","treatment_end_date":"2022-02","treatment_setting":"Mobilization","treatment_intent":null,"days_per_cycle":3,"number_of_cycles":5,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":"Immune confirmed progressive disease (iCPD)","line_of_treatment":1,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_treatment_id":null,"program_id":null,"submitter_donor_id":null,"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy","Surgery"],"is_primary_treatment":"Unknown","treatment_start_date":"2021-12","treatment_end_date":"2022-08","treatment_setting":null,"treatment_intent":"Forensic","days_per_cycle":5,"number_of_cycles":5,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":null,"line_of_treatment":5,"status_of_treatment":"Treatment completed as prescribed"},
{"submitter_treatment_id":null,"program_id":null,"submitter_donor_id":null,"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":null,"treatment_start_date":"2021-10","treatment_end_date":"2022-08","treatment_setting":"Induction","treatment_intent":"Diagnostic","days_per_cycle":2,"number_of_cycles":3,"response_to_treatment_criteria_method":"Cheson CLL 2012 Oncology Response Criteria","response_to_treatment":null,"line_of_treatment":null,"status_of_treatment":null},
{"submitter_treatment_id":null,"program_id":null,"submitter_donor_id":null,"submitter_primary_diagnosis_id":"","treatment_type":["Surgery"],"is_primary_treatment":"Unknown","treatment_start_date":"2021-02","treatment_end_date":"2022-05","treatment_setting":"Salvage","treatment_intent":"Supportive","days_per_cycle":3,"number_of_cycles":3,"response_to_treatment_criteria_method":null,"response_to_treatment":"Partial response","line_of_treatment":1,"status_of_treatment":null},
{"submitter_treatment_id":null,"program_id":null,"submitter_donor_id":null,"submitter_primary_diagnosis_id":"","treatment_type":["Immunotherapy"],"is_primary_treatment":"Yes","treatment_start_date":"2021-03","treatment_end_date":"2022-04","treatment_setting":"Mobilization","treatment_intent":"Diagnostic","days_per_cycle":3,"number_of_cycles":3,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Partial remission","line_of_treatment":4,"status_of_treatment":null},
{"submitter_treatment_id":null,"program_id":null,"submitter_donor_id":null,"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant"],"is_primary_treatment":"Yes","treatment_start_date":"2021-09","treatment_end_date":"2022-06","treatment_setting":"Mobilization","treatment_intent":"Palliative","days_per_cycle":4,"number_of_cycles":4,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":"Progressive disease","line_of_treatment":3,"status_of_treatment":null},
{"submitter_treatment_id":null,"program_id":null,"submitter_donor_id":null,"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Stem cell transplant"],"is_primary_treatment":"No","treatment_start_date":"2021-12","treatment_end_date":"2022-06","treatment_setting":null,"treatment_intent":"Preventive","days_per_cycle":6,"number_of_cycles":4,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Major response","line_of_treatment":5,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_treatment_id":null,"program_id":null,"submitter_donor_id":null,"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy"],"is_primary_treatment":"No","treatment_start_date":null,"treatment_end_date":"2022-09","treatment_setting":"Maintenance","treatment_intent":"Curative","days_per_cycle":7,"number_of_cycles":5,"response_to_treatment_criteria_method":null,"response_to_treatment":"Partial response","line_of_treatment":null,"status_of_treatment":"Treatment stopped due to acute toxicity"},
{"submitter_treatment_id":null,"program_id":null,"submitter_donor_id":null,"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":"2021-06","treatment_end_date":null,"treatment_setting":"Salvage","treatment_intent":null,"days_per_cycle":1,"number_of_cycles":null,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Immune complete response (iCR)","line_of_treatment":1,"status_of_treatment":"Not applicable"},
{"submitter_treatment_id":null,"program_id":null,"submitter_donor_id":null,"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":"2021-04","treatment_end_date":"2022-02","treatment_setting":"Induction","treatment_intent":"Forensic","days_per_cycle":1,"number_of_cycles":3,"response_to_treatment_criteria_method":null,"response_to_treatment":"Immune confirmed progressive disease (iCPD)","line_of_treatment":null,"status_of_treatment":null},
{"submitter_treatment_id":null,"program_id":null,"submitter_donor_id":null,"submitter_primary_diagnosis_id":"","treatment_type":[],"is_primary_treatment":"Yes","treatment_start_date":"2021-09","treatment_end_date":"2022-05","treatment_setting":"Radiosensitization","treatment_intent":"Diagnostic","days_per_cycle":5,"number_of_cycles":null,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":"Stable disease","line_of_treatment":3,"status_of_treatment":"Treatment incomplete because patient died"},
{"submitter_treatment_id":null,"program_id":null,"submitter_donor_id":null,"submitter_primary_diagnosis_id":"","treatment_type":["No treatment"],"is_primary_treatment":"No","treatment_start_date":"2021-02","treatment_end_date":"2022-03","treatment_setting":"Preventative","treatment_intent":"Preventive","days_per_cycle":null,"number_of_cycles":3,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Immune complete response (iCR)","line_of_treatment":1,"status_of_treatment":"Patient choice (stopped or interrupted treatment)"},
{"submitter_treatment_id":null,"program_id":null,"submitter_donor_id":null,"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant"],"is_primary_treatment":null,"treatment_start_date":null,"treatment_end_date":"2022-03","treatment_setting":"Maintenance","treatment_intent":"Diagnostic","days_per_cycle":1,"number_of_cycles":5,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":"Complete remission with incomplete hematologic recovery (CRi)","line_of_treatment":null,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_treatment_id":null,"program_id":null,"submitter_donor_id":null,"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy","Surgery","Photodynamic therapy"],"is_primary_treatment":null,"treatment_start_date":null,"treatment_end_date":"2022-05","treatment_setting":"Neoadjuvant","treatment_intent":"Guidance","days_per_cycle":null,"number_of_cycles":4,"response_to_treatment_criteria_method":"RECIST 1.1","response_to_treatment":null,"line_of_treatment":2,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_treatment_id":null,"program_id":null,"submitter_donor_id":null,"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant"],"is_primary_treatment":"Unknown","treatment_start_date":"2021-12","treatment_end_date":"2022-01","treatment_setting":"Maintenance","treatment_intent":null,"days_per_cycle":7,"number_of_cycles":4,"response_to_treatment_criteria_method":"AML Response Criteria","response_to_treatment":"Progressive disease","line_of_treatment":2,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_treatment_id":null,"program_id":null,"submitter_donor_id":null,"submitter_primary_diagnosis_id":"","treatment_type":["Other targeting molecular therapy","Immunotherapy"],"is_primary_treatment":"No","treatment_start_date":null,"treatment_end_date":"2022-05","treatment_setting":null,"treatment_intent":"Palliative","days_per_cycle":4,"number_of_cycles":3,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Partial remission","line_of_treatment":2,"status_of_treatment":"Treatment incomplete due to technical or organizational problems"},
{"submitter_treatment_id":null,"program_id":null,"submitter_donor_id":null,"submitter_primary_diagnosis_id":"","treatment_type":["No treatment","Surgery","Bone marrow transplant"],"is_primary_treatment":"Yes","treatment_start_date":"2021-12","treatment_end_date":"2022-04","treatment_setting":"Adjuvant","treatment_intent":"Preventive","days_per_cycle":3,"number_of_cycles":null,"response_to_treatment_criteria_method":"Physician Assessed Response Criteria","response_to_treatment":null,"line_of_treatment":4,"status_of_treatment":"Other"},
{"submitter_treatment_id":null,"program_id":null,"submitter_donor_id":null,"submitter_primary_diagnosis_id":"","treatment_type":["Photodynamic therapy"],"is_primary_treatment":"Yes","treatment_start_date":"2021-05","treatment_end_date":"2022-07","treatment_setting":"Induction","treatment_intent":"Diagnostic","days_per_cycle":null,"number_of_cycles":4,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Hematologic relapse (after CR MRD-, CR, CRi)","line_of_treatment":null,"status_of_treatment":null},
{"submitter_treatment_id":null,"program_id":null,"submitter_donor_id":null,"submitter_primary_diagnosis_id":"","treatment_type":["Chemotherapy"],"is_primary_treatment":"Unknown","treatment_start_date":"2021-11","treatment_end_date":"2022-03","treatment_setting":"Locally advanced","treatment_intent":"Diagnostic","days_per_cycle":4,"number_of_cycles":5,"response_to_treatment_criteria_method":null,"response_to_treatment":"Complete response","line_of_treatment":3,"status_of_treatment":"Treatment stopped due to lack of efficacy (disease progression)"},
{"submitter_treatment_id":null,"program_id":null,"submitter_donor_id":null,"submitter_primary_diagnosis_id":"","treatment_type":["No treatment"],"is_primary_treatment":"Yes","treatment_start_date":"2021-03","treatment_end_date":"2022-10","treatment_setting":"Radiosensitization","treatment_intent":"Preventive","days_per_cycle":null,"number_of_cycles":3,"response_to_treatment_criteria_method":"iRECIST","response_to_treatment":null,"line_of_treatment":null,"status_of_treatment":null},
{"submitter_treatment_id":null,"program_id":null,"submitter_donor_id":null,"submitter_primary_diagnosis_id":"","treatment_type":["Radiation therapy","Surgery","Hormonal therapy"],"is_primary_treatment":"Yes","treatment_start_date":"2021-08","treatment_end_date":"2022-03","treatment_setting":"Salvage","treatment_intent":"Screening","days_per_cycle":4,"number_of_cycles":null,"response_to_treatment_criteria_method":"Blazer score","response_to_treatment":"Partial remission","line_of_treatment":2,"status_of_treatment":null},
{"submitter_treatment_id":null,"program_id":null,"submitter_donor_id":null,"submitter_primary_diagnosis_id":"","treatment_type":["Stem cell transplant","Surgery"],"is_primary_treatment":"No","treatment_start_date":"2021-10","treatment_end_date":"2022-01","treatment_setting":"Maintenance","treatment_intent":"Curative","days_per_cycle":2,"number_of_cycles":4,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Complete remission without measurable residual disease (CR MRD-)","line_of_treatment":null,"status_of_treatment":"Physician decision (stopped or interrupted treatment)"},
{"submitter_treatment_id":null,"program_id":null,"submitter_donor_id":null,"submitter_primary_diagnosis_id":"","treatment_type":["Bone marrow transplant","No treatment"],"is_primary_treatment":"Unknown","treatment_start_date":"2021-11","treatment_end_date":"2022-05","treatment_setting":"Radiosensitization","treatment_intent":"Curative","days_per_cycle":6,"number_of_cycles":3,"response_to_treatment_criteria_method":"Response Assessment in Neuro-Oncology (RANO)","response_to_treatment":"Complete response","line_of_treatment":null,"status_of_treatment":"Treatment stopped due to acute toxicity"}]